Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaneto Uekama

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 4, 2004
[Pharmaceutical application of cyclodextrins as multi-functional drug carriers]Kaneto Uekama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2012
[Novel approach of cyclodextrin-based pharmaceutical formulation]Kaneto Uekama
Chemical & Pharmaceutical Bulletin|August 12, 2004
Design and evaluation of cyclodextrin-based drug formulationKaneto Uekama
Chemical Reviews|February 19, 2002
Cyclodextrin Drug Carrier SystemsKaneto Uekama, Fumitoshi Hirayama, Tetsumi Irie
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2007
Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA)Toshihito Tsutsumi, Fumitoshi Hirayama, Kaneto Uekama, et al.
Chemical & Pharmaceutical Bulletin|September 3, 2019
Modification of Drug Crystallization by Cyclodextrins in Pre-formulation StudyDaisuke Iohara, Makoto Anraku, Kaneto Uekama, et al.
FEBS Letters|February 15, 2003
Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cellsKiyokazu Yunomae, Hidetoshi Arima, Fumitoshi Hirayama, et al.
Journal of Drug Targeting|June 17, 2006
Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomesHidetoshi Arima, Yoshiyuki Hagiwara, Fumitoshi Hirayama, et al.
Journal of Pharmaceutical Sciences|June 24, 2006
Enhanced bioavailability of a new thiazolidine derivative FPFS-410, an antidiabetic and lipid-lowering drug, after oral administration of its hydroxypropyl-beta-cyclodextrin complex to bile duct-cannulated ratsTakumi Hara, Hidetoshi Arima, Fumitoshi Hirayama, et al.
Journal of Pharmaceutical Sciences|October 13, 2007
Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNAToshihito Tsutsumi, Fumitoshi Hirayama, Kaneto Uekama, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|December 4, 2004
[Pharmaceutical application of cyclodextrins as multi-functional drug carriers]Kaneto Uekama
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|January 5, 2012
[Novel approach of cyclodextrin-based pharmaceutical formulation]Kaneto Uekama
Chemical & Pharmaceutical Bulletin|August 12, 2004
Design and evaluation of cyclodextrin-based drug formulationKaneto Uekama
Chemical Reviews|February 19, 2002
Cyclodextrin Drug Carrier SystemsKaneto Uekama, Fumitoshi Hirayama, Tetsumi Irie
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2007
Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA)Toshihito Tsutsumi, Fumitoshi Hirayama, Kaneto Uekama, et al.
Chemical & Pharmaceutical Bulletin|September 3, 2019
Modification of Drug Crystallization by Cyclodextrins in Pre-formulation StudyDaisuke Iohara, Makoto Anraku, Kaneto Uekama, et al.
FEBS Letters|February 15, 2003
Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cellsKiyokazu Yunomae, Hidetoshi Arima, Fumitoshi Hirayama, et al.
Journal of Drug Targeting|June 17, 2006
Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomesHidetoshi Arima, Yoshiyuki Hagiwara, Fumitoshi Hirayama, et al.
Journal of Pharmaceutical Sciences|June 24, 2006
Enhanced bioavailability of a new thiazolidine derivative FPFS-410, an antidiabetic and lipid-lowering drug, after oral administration of its hydroxypropyl-beta-cyclodextrin complex to bile duct-cannulated ratsTakumi Hara, Hidetoshi Arima, Fumitoshi Hirayama, et al.
Journal of Pharmaceutical Sciences|October 13, 2007
Potential use of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for short hairpin RNA-expressing plasmid DNAToshihito Tsutsumi, Fumitoshi Hirayama, Kaneto Uekama, et al.
Pageof 9